Medanta Enhances its Cancer Care Program with the Latest Varian EDGE Radiation Machine

▴ Medanta Enhances its Cancer Care
First hospital in India to launch radiation machine equipped with IDENTIFY HyperArc, and RapidArc Dynamic technology, along with cones for functional SRS.

National, December 19, 2025 – Medanta – The Medicity, ranked the Best Private Hospital in India by Newsweek for six consecutive years, has launched the country’s most advanced Varian EDGE radiation therapy system, which for the first time comes integrated with IDENTIFY® surface-guided technology, HyperArc™, RapidArc® Dynamic therapy, and functional SRS cones. With this development, Medanta has greatly enhanced its cancer care program and its leadership in oncology.

This next-generation radiation platform significantly reduces treatment time to nearly one minute per session for most cancers, while delivering sub-millimetric precision, enabling superior tumor targeting with minimal exposure to surrounding healthy tissue. This results in faster, safer, and more comfortable radiation therapy, even for complex and high-risk tumors.

 

Dr. Naresh Trehan, Chairman & Managing Director, Medanta emphasized technology’s pivotal role in the hospital’s enduring commitment to delivering world-class, patient-centric care. He said, “Technology is driving a revolution in healthcare and its participation in the enhancement of medicine is a huge importance to humanity. We have opted for the latest equipment as we are steadfast in our commitment to deliver the best in healthcare, reflected in the Medanta ethos – ‘Har Ek Jaan Anmol’ (Every Life Is Invaluable).”

 

Dr. Tejinder Kataria, Chairperson, Radiation Oncology, Cancer Care at Medanta –The Medicity said, “Designed to treat a broad spectrum of cancers -- including multiple brain metastases, head and neck cancers, breast cancer, and lung cancer -- this equipment enhances both clinical accuracy and patient experience, reinforcing Medanta’s commitment to world-class, patient-first oncology care.”

The new machine integrates real-time surface-guided radiation therapy (SGRT) through IDENTIFY®, allowing continuous monitoring of patient positioning during treatment. This ensures immediate correction or the automatic cessation of radiation if the patient moves out of position. This enhances safety across all age groups, including pediatric patients. Importantly, patients of most cancers no longer require a thermoplastic cast, which is typically used to securely hold the patient in place during radiation treatment.

 

Advanced capabilities enable clinicians to customize radiation dose distribution with exceptional precision, including HyperArc™ -- an isocentric technique for volumetric modulated arc therapy (VMAT) that delivers a high dose of radiation to tumors while sparing surrounding healthy tissue -- and RapidArc® Dynamic therapy, which allows clinicians to customize the radiation’s distribution to optimal degrees. The inclusion of functional stereotactic radiosurgery (SRS) cones also allows the treatment of select benign brain conditions with high accuracy.

 

Dr. Kataria also added, “We have come a long way from a nihilistic approach to treating cancer and towards radiation delivery over the past four decades. In the new machine, computer algorithms and the rapid dynamic movement of the multileaf collimator, along with the assembly around the patient, delivers the sub-millimeter precision in the delivery of the treatment.”

 

About Global Health Limited (Medanta):

Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest civilian awards in India, and the Dr. B.C. Roy Award in recognition of his distinguished contribution to medicine.

 

Global Health Limited (the “Company”) is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, with key specialties cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology, according to the report titled “An assessment of the healthcare delivery market in India, September 2022” by CRISIL Limited.

 

Under the “Medanta” brand, the Company has a network of six hospitals currently in operation (Gurgaon, Indore, Ranchi, Lucknow, Patna and Noida). Spanning an area of 5.6 million sq. ft., its operational hospitals have 3,435 installed beds as on September 30, 2025. It also has four upcoming hospitals in Mumbai, Pitampura - New Delhi, South Delhi and Guwahati. The Company provides healthcare services in over 30 medical specialties and engages over 2,150 + doctors led by highly experienced department heads.

 

 

 

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026